Dr Reddy’s Laboratories

Dr Reddy’s launches generic lipid-regulating tablets in US

Read more

Dr Reddy’s launches generic opioid antagonist injection in US

Read more

Dr Reddy’s launches generic Ziprasidone Mesylate for injection in US

Read more

Satish Reddy elected CII SR Chairman

Read more

Female workforce in pharma: Knocking on the glass ceiling?

Read more

Dr Reddy’s launches generic version of Vimovo tablets in US market

Read more

Dr Reddy’s to acquire Wockhardt’s select generics for Rs 1850 crore

Read more

Pharma Budget 2020

Read more

TechMahindra and Wipro join Dr Reddy’s Laboratories on the Bloomberg Gender-Equality Index

Read more

Dr Reddy’s Laboratories enters nutrition segment with ‘Celevida’ in India

Read more